Manager, Complaints and Post-Market
Noah MedicalSalary not specified
- Full Time
- Junior (1 to 2 years)
About Noah Medical
Noah Medical creates medical robotic solutions to improve early diagnosis in pulmonology. Their main product, the Galaxy System™ with TiLT+ Technology™, enhances diagnostic accuracy by providing real-time navigation and an augmented fluoro feature for locating lesions. The system is designed for efficiency with a single-use bronchoscope that reduces cross-contamination risks and improves workflow. Noah Medical stands out by collaborating with leading pulmonologists to ensure their technology meets practical clinical needs.
Redwood City, CaliforniaHeadquarters
2018Year Founded
$145.9MTotal Funding
SERIES_BCompany Stage
Robotics & Automation, HealthcareIndustries
201-500Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Legal Services
Pet Insurance
12+ Paid Holidays
15-20 Days of PTO
Paid Parental Leave
In-office Snacks and Beverages
In-office Lunch Stipend
Learning & Development Opportunities
Team Building and Company Organized Social Events
Hybrid Work Options
Risks
Increased competition from established companies like Intuitive Surgical in robotic bronchoscopy.
Potential delays in regulatory approvals could impact market entry and sales.
High cost of the Galaxy System™ may limit adoption in smaller healthcare facilities.
Differentiation
Noah Medical's Galaxy System™ offers real-time navigation updates for lung procedures.
The system's single-use bronchoscope reduces cross-contamination and improves procedural efficiency.
Compact design of the Galaxy System™ suits crowded bronch suites and operating rooms.
Upsides
Growing demand for minimally invasive procedures aligns with Noah Medical's focus.
Rising investment in healthcare technology startups offers funding opportunities for Noah Medical.
Advancements in AI enhance real-time image processing in Noah Medical's robotic systems.
Funding
Total raised$145.91 M
Latest valuation$750.00 M
StageSERIES_B